CIARMELA, Pasquapina
 Distribuzione geografica
Continente #
NA - Nord America 4.232
EU - Europa 2.524
AS - Asia 1.406
SA - Sud America 241
AF - Africa 73
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 1
Totale 8.487
Nazione #
US - Stati Uniti d'America 4.189
IT - Italia 622
SG - Singapore 536
CN - Cina 376
UA - Ucraina 336
RU - Federazione Russa 270
DE - Germania 269
BR - Brasile 218
IE - Irlanda 195
RO - Romania 169
SE - Svezia 164
HK - Hong Kong 146
DK - Danimarca 121
FI - Finlandia 115
TR - Turchia 96
FR - Francia 87
VN - Vietnam 79
GB - Regno Unito 74
KR - Corea 67
CI - Costa d'Avorio 36
IN - India 35
CA - Canada 23
ES - Italia 20
NL - Olanda 18
BD - Bangladesh 17
AT - Austria 16
MX - Messico 16
PL - Polonia 15
BE - Belgio 13
MA - Marocco 12
IQ - Iraq 11
EU - Europa 10
JP - Giappone 9
ZA - Sudafrica 9
RS - Serbia 7
AR - Argentina 6
KE - Kenya 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
ID - Indonesia 4
JO - Giordania 4
NG - Nigeria 4
UZ - Uzbekistan 4
LT - Lituania 3
PE - Perù 3
SA - Arabia Saudita 3
BO - Bolivia 2
CH - Svizzera 2
CL - Cile 2
EC - Ecuador 2
IL - Israele 2
IR - Iran 2
LY - Libia 2
MY - Malesia 2
PK - Pakistan 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CO - Colombia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GR - Grecia 1
HN - Honduras 1
JM - Giamaica 1
KG - Kirghizistan 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
PY - Paraguay 1
SN - Senegal 1
TN - Tunisia 1
TV - Tuvalu 1
Totale 8.487
Città #
Ashburn 511
Chandler 390
Singapore 361
Jacksonville 342
Fairfield 340
Dallas 244
Boardman 195
Dublin 195
Brasov 168
New York 154
Wilmington 148
Hong Kong 140
Houston 132
Woodbridge 129
Seattle 119
Centro 114
Ann Arbor 107
Cambridge 103
Beijing 98
Ancona 83
Los Angeles 82
Lawrence 77
Princeton 77
Munich 76
San Mateo 72
Des Moines 60
The Dalles 57
Redmond 50
Hefei 45
Moscow 41
Guangzhou 37
San Diego 37
Abidjan 36
Turku 33
Buffalo 30
Ho Chi Minh City 27
Marche 27
Rome 27
Washington 27
Helsinki 25
London 25
São Paulo 25
Turin 24
Botticino 23
Cantu 20
Frankfurt am Main 17
Shanghai 17
Baltimore 15
Chicago 15
Brussels 13
Hanoi 13
Montreal 13
Santa Clara 13
Tolentino 13
Warsaw 12
Belo Horizonte 11
Brooklyn 11
Chennai 11
Denver 11
Vienna 11
Columbus 10
Milan 10
Pune 10
San Francisco 10
Ankara 9
Berlin 9
Norwalk 9
Orem 9
Phoenix 9
Cingoli 8
Mexico City 8
Stockholm 8
Amsterdam 7
Kilburn 7
Redwood City 7
Bologna 6
Boston 6
Dhaka 6
Jesi 6
Jinhua 6
Nuremberg 6
Poplar 6
Ferrara 5
Johannesburg 5
Montelabbate 5
Mountain View 5
Nairobi 5
Rio de Janeiro 5
Secaucus 5
Terzigno 5
Wuhan 5
Amman 4
Atlanta 4
Biên Hòa 4
Florence 4
Indianapolis 4
Menlo Park 4
Montecassiano 4
Nantong 4
Squinzano 4
Totale 5.582
Nome #
Romina: A powerful strawberry with in vitro efficacy against uterine leiomyoma cells 228
ESTRATTO CONCENTRATO DI FRUTTI DI FRAGOLE CON ALTA CAPACITA' ANTIOSSIDANTE PER IL TRATTAMENTO E LA PREVENZIONE DEI LEIOMIOMI UTERINI E METODO PER L'OTTENIMENTO DELL'ESTRATTO 199
RKIP in Uterine Tissues 195
Apparecchiatura per l'allenamento dell'equilibrio 189
Omega-3 fatty acids modulate the lipid profile, membrane architecture, and gene expression of leiomyoma cells 184
An anthocyanin rich strawberry extract induces apoptosis and ROS while decreases glycolysis and fibrosis in human uterine leiomyoma cells 174
Growth factors and pathogenesis 165
Possible involvement of inflammatory/reparative processes in the development of uterine fibroids 164
Advanced 3D Imaging of Uterine Leiomyoma’s Morphology by Propagation-based Phase-Contrast Microtomography 163
Activin A in Inflammation, Tissue Repair, and Fibrosis: Possible Role as Inflammatory and Fibrotic Mediator of Uterine Fibroid Development and Growth 158
Quercetin and indole-3-carbinol inhibit extracellular matrix expression in human primary uterine leiomyoma cells 158
Activin-A and myostatin response and steroid regulation in human myometrium: disruption of their signalling in uterine fibroid. 146
Role of activin-A and myostatin and their signaling pathway in human myometrial and leiomyoma cell function. 143
Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics 143
Activating protein-1 family transcription factors in the human placenta complicated by preeclampsia with and without fetal growth restriction. 139
Placental Expression of CD100,CD72, and CD45 Is Dysregulated in Human Miscarriage. 134
IL-1β and TGF-β weaken the placental barrier through destruction of tight junctions: An in vivo and in vitro study. 133
Locostatin, a disrupter of Raf kinase inhibitor protein, inhibits extracellular matrix production, proliferation, and migration in human uterine leiomyoma and myometrial cells 133
Tranilast, an orally active antiallergic compound, inhibits extracellular matrix production in human uterine leiomyoma and myometrial cells 132
Uterine fibroid vascularization: from morphological evidence to clinical implications 124
Use of dietary phytochemicals to target inflammation, fibrosis, proliferation, and angiogenesis in uterine tissues: Promising options for prevention and treatment of uterine fibroids? 119
Uterine Fibroids: Pathogenesis and Interactions with Endometrium and Endomyometrial Junction. 119
Uterine leiomyoma as useful model to unveil morphometric and macromolecular collagen state and impairment in fibrotic diseases: An ex-vivo human study 118
Activin A in Mammalian Physiology 117
Omega 3 fatty acid modulate cell membrane architecture and specific gene expression in myometrial and leiomyoma cells 115
Deep Infiltrating Endometriosis and Endometrial Adenocarcinoma Express High Levels of Myostatin and Its Receptors Messenger RNAs 112
Complex networks of multiple factors in the pathogenesis of uterine leiomyoma. 109
High levels of hypusinated eIF5A in leiomyoma and leiomyosarcoma pathologies: a possible novel therapeutic target 108
Effects of omega-3 fatty acids on uterine leiomyoma cell membranes 107
Molecular targets of dietary phytochemicals for possible prevention and therapy of uterine fibroids: Focus on fibrosis 107
Pathogenesis of Endometriosis and Uterine Fibroids 106
Ulipristal Acetate Modulates the Expression and Functions of Activin A in Leiomyoma Cells 105
Macrophages and Immune Responses in Uterine Fibroids 105
Activin-related proteins in bovine mammary gland: Localization and differential expression during gestational development and differentiation. 105
TGF beta family members function in uterine healthy and fibrotic smooth muscle cells. 103
Dietary phytochemicals for possible preventive and therapeutic option of uterine fibroids: Signaling pathways as target 103
Hop and artichoke extracts inhibit expression of extracellular matrix components in uterine leiomyoma cells 102
The Agrobacterium tumefaciens is a potential tool for antitumor study. 100
Increased expression of neurogenic factors in uterine fibroids 100
Management of leiomyomas in perimenopausal women 99
Autophagy up-regulation by ulipristal acetate as a novel target mechanism in the treatment of uterine leiomyoma: an in vitro study 99
Raf kinase inhibitor protein expression in smooth muscle tumours of the uterus: a diagnostic marker for leiomyosarcoma? 98
Differential expression of follistatin and FLRG in human breast proliferative disorders. 98
Analysis of cell-cell junctions in human amnion and chorionic plate affected by chorioamnionitis 98
Analysis of tight junctions in placentas affected by chorioamnionitis: in vivo and in vitro analysis. 94
Changes of inhibins and activin secretion in healthy and pathological pregnancy. 90
Management of fibroids in perimenopausal women 87
Establishment of 3D Cultures of Myometrium, Leiomyoma, and Leiomyosarcoma Cells: Advantages and Disadvantages of Two Different Models 85
Molecular aspects of adipoepithelial transdifferentiation in mouse mammary gland 84
FTIR Microspectroscopy as a new probe to study human uterine lesions: Characterization of tumor cell lines from uterine smooth muscle cells and evaluation of EPA and DHA in vitro treatments 82
Activin mediators and modulators. 80
Sphingosine 1-phosphate signaling in uterine fibroids: implication in activin A pro-fibrotic effect 80
Phytoprogestins: Unexplored food compounds with potential preventive and therapeutic effects in female diseases 80
3D-Printed Alginate-Based Hydrogels with Appropriate Rheological Properties and Efficient Development of Cell Spheroids 77
High levels of intrauterine corticotrophin-releasing hormone, urocortin, tryptase, and interleukin-8 in spontaneous abortions. 77
Stress and preterm birth. Neuro-endocrine background of acute and chronic stress initiating preterm delivery | [Stress und frühgeburt: Neuroendokriner hintergrund von akutem und chronischem stress als auslöser für eine frühgeburt] 76
Uterine leiomyoma: available medical treatments and new possible therapeutic options. 75
New epigenetic mechanism involved in leiomyoma formation 75
Polymorphsms of FAS and FAS ligand genes in preeclamptic women 74
RKIP and cytotrophoblast motility 73
Activin-A in myometrium: characterization of the actions on myometrial cells. Endocrinology. 73
Expression Levels of Myostatin and Matrix Metalloproteinase 14 mRNAs in Uterine Leiomyoma are Correlated with Dysmenorrhea 72
Endothelial cell alterations in capillaries of adipose tissue from patients affected by lipedema 70
The In Vitro Effects of Romina Strawberry Extract on 3D Uterine Leiomyosarcoma Cells 70
Presence, actions, and regulation of myostatin in rat uterus and myometrial cells. 69
Expression, localization and control of activin A release from human umbilical vein endothelial cells 68
Endometrial expression and secretion of activin A, but not follistatin, increase in the secretory phase of the menstrual cycle. 67
Pre-eclampsia with fetal growth restriction: placental and serum activin A and inhibin A levels. 64
Paracrine regulation of endometrial function: interaction between progesterone and corticotropin-releasing factor (CRF) and activin A. 63
Placental stress factors and maternal-fetal adaptive response: the corticotropin-releasing factor family. 63
Identification of Urocortin mRNA and Peptide in the Human Endometrium. 63
Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications. 61
Follistatin-related gene expression, but not follistatin expression, is decreased in human endometrial adenocarcinoma. 61
Human endometrium and decidua express follistatin-related gene (FLRG) mRNA and peptide. 61
PCR amplification and polymorphism analysis of the intergenic spacer region of ribosomal DNA in Tuber borchii. 60
Structural analysis of the rDNA intergenic spacer of Tuber borchii. 60
Mutational analysis of the inhibin alpha gene in preeclamptic women. 60
Inhibins and activins in pregnancy. 59
Possible role of RKIP in cytotrophoblast migration: immunohistochemical and in vitro studies. 59
Human placenta and fetal membranes express nerve growth factor mRNA and protein. J Endocrinol Invest. 55
Human placenta and fetal membranes express follistatin-related gene (FLRG) mRNA and protein. 53
Impact of Nutrition on Female Reproductive Disorders 52
Inhibin alpha-subunit and the inhibin coreceptor betaglycan are downregulated in endometrial carcinoma. 52
Evaluation of transcript level and biomass during mycelial development of the truffle, Tuber borchii 51
Expression of betaglycan in pregnant tissues throughout gestation 50
Nutrition in Gynecologic Disease 38
Sphingosine 1-phosphate acts as proliferative and fibrotic cue in leiomyoma cells 32
null 19
Transparent tissue phantoms 3D printed in alginate, collagen and gelatin naturally crosslinked 16
Apparecchiatura per allenamento dell'equilibrio 1
Totale 8.687
Categoria #
all - tutte 44.594
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.594


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021745 0 0 0 0 0 126 104 82 107 168 122 36
2021/2022904 51 167 31 18 5 30 45 34 50 52 102 319
2022/20231.151 116 143 89 80 75 132 5 84 273 6 99 49
2023/2024849 115 25 58 94 126 170 17 13 7 64 11 149
2024/20251.450 96 109 53 24 68 38 106 61 416 114 161 204
2025/20261.790 339 250 268 299 453 181 0 0 0 0 0 0
Totale 8.687